Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP651321.RAfERMph_cjEqsvUKuTpVcsiO3cmWhkjDOOd4jWmdPNks130_assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651321.RAfERMph_cjEqsvUKuTpVcsiO3cmWhkjDOOd4jWmdPNks130_provenance.
• NP207165.RAhyt77dgbxTfFpJ-3YKd68F_sCMO242Sa59BjOP5iDUU130_assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207165.RAhyt77dgbxTfFpJ-3YKd68F_sCMO242Sa59BjOP5iDUU130_provenance.
• NP262279.RAk_8aILRe53x9JUnrAMR52vf9M6b_qzUWs8eBHtTDZMk130_assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262279.RAk_8aILRe53x9JUnrAMR52vf9M6b_qzUWs8eBHtTDZMk130_provenance.
• NP277591.RAJbEy9k9V8MURkqR8SdjS2SHyV8xot_KZ8f3v-sc59Po130_assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP277591.RAJbEy9k9V8MURkqR8SdjS2SHyV8xot_KZ8f3v-sc59Po130_provenance.
• NP799127.RAyvNJa1dio0C3WrTy8Qqi5Pgwiay0XVzc1jaZFo8cVMY130_assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP799127.RAyvNJa1dio0C3WrTy8Qqi5Pgwiay0XVzc1jaZFo8cVMY130_provenance.
• NP647130.RAHD2KxSq1hVkJdxOmqhBMYGPqLWgjbAfsDexWQea1ZTY130_assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP647130.RAHD2KxSq1hVkJdxOmqhBMYGPqLWgjbAfsDexWQea1ZTY130_provenance.
• assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP879158.RABG-lCru5x5y-Hlw_jWv68ms9Qa9KBuyRoHMHxbE-BWI130_assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879158.RABG-lCru5x5y-Hlw_jWv68ms9Qa9KBuyRoHMHxbE-BWI130_provenance.
• NP879157.RAsFFuNLN3THUTGJIAhJR1Pr4-5z1jd2ev2r1QdMCbx5w130_assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879157.RAsFFuNLN3THUTGJIAhJR1Pr4-5z1jd2ev2r1QdMCbx5w130_provenance.
• NP879154.RAJwg530IwMth_8pZINNLbIQ2bUj-yuoY_NG_ghR_xO0o130_assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879154.RAJwg530IwMth_8pZINNLbIQ2bUj-yuoY_NG_ghR_xO0o130_provenance.
• NP879156.RAK5-fYLgemNs9eVe5vnoxoFb-IEnvkZTaVCN009LI0DQ130_assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879156.RAK5-fYLgemNs9eVe5vnoxoFb-IEnvkZTaVCN009LI0DQ130_provenance.